Articles

In its continuing quest to play a part in every step of the cataract procedure Alcon is to acquire LenSx Lasers Inc., for $361.5 million in cash

As editor of Ophthalmology Times Europe I would like to hear your views about choices you make on behalf of your patients.

British and German scientists Dr Claus Cursiefen and his colleagues have reported that transplanted corneas are more likely to fail or be rejected in patients whose eyes exhibit abnormal vessel growth, called corneal neovascularization, before surgery.

Ophthalmic Women Leaders (OWL) and Women In Ophthalmology, Inc. (WIO) are pleased to announce their joint partnership in presenting the WIO Summer Symposium.

The French EyeOP1 medical device, from EyeTechCare, is a novel and non-invasive treatment for glaucoma that is based on the use of high-intensity focused ultrasound (HIFUs). The product is set to become available at the end of 2010

The merger Novartis has been trying to unilaterally impose on Alcon cannot go ahead without the approval of Alcon's Independent Director Committee (IDC), according to a legal expert

Ophthalmic instrument and replacement lens business, Ophtec BV, has expanded its business into the Far East with a site based in Japan.

Scientists in The Netherlands have received an innovation grant to finalise the specification of a collagen, derived from fishscale, which will act as an alternative material for cornea regeneration.

President of the Middle East African Council of Ophthalmology (MEACO), Dr Abdulaziz Al Rajhi, is to become president of the World Ophthalmology Congress (WOC) 2012.

Dr Joachim Storsberg at the Fraunhofer Institute for Applied Polymer Research in Germany has developed an artificial cornea. The ophthalmological polymer is designed to bond to the eye but remain unclouded by cells in its centre.

Alcon Inc. is to sponsor a four-week ophthalmic skills exchange and surgical programme through ORBIS International?s signature Flying Eye Hospital.

France Lens has launched, The Concept Asphilens 1.8, a new aspheric implant specifically designed for microincision cataract surgery (MICS).

As part of last week's National Eye Health Week in the UK, Spectrum Théa, the independent ophthalmic company, looked at things from a patient's perspective.

The Pediatric Cataract Initiative ( ), sponsored by the Bausch + Lomb Early Vision Institute and Lions Clubs International Foundation, has announced its inaugural global advisory council.

Fight for Sight, a UK leading eye research charity, has awarded two new grants totalling £350,000 for research into glaucoma ? one of the leading causes of preventable blindness in the UK

In a sample of moderate evaporative-type dry eye disease patients Enriquez-de-Salamanca et al., elevated five inflammatory molecules. Fracktalkine was demonstrated to be present and elevated in tears in human DED.

A new disinfecting technology for soft contact lenses from Abbott has received European regulatory approval. Complete RevitaLens Multipurpose Disinfecting Solution was developed in partnership with the Holden Vision Institute.

This year's highly prestigious Champalimaud Vision Award is shared between two worthy winners for their ground-breaking research in neuroscience and how the brain contructs images.

Carl Zeiss Meditec presented its expanded offering of ophthalmic solutions at this year's WOC 2010 in Berlin.

Optimax has refined its Intralase technology to introduce what it calls 'unprecedented' levels of control for its surgeons through the rollout of the new generation iFS IntraLase Lasers across its UK clinics.

OTE Editorial Advisory Board Member, Professor Gisele Soubrane has become the first woman to receive an International Council of Ophthalmology (ICO) medal.

Retinal imaging company, Optos Plc having made a return to profitability is taking its Optomap Retinal Exam to the ophthalmology community and had a strong presence at this year?s WOC in Berlin.

In his presentation at the World Ophthalmology Congress, Dr Matthew Benz highlighted that the first Phase III trial with microplasmin (TG-MV-006) for the non-surgical treatment of vitreomacular adhesion (VMA) had met its primary endpoint with 27.7% of the 220 microplasmin treated patients achieving resolution of their VMA at 1 month, compared to 13.2% of the 106 patients who received a placebo injection, a highly statistically significant result (p=0.003).

Dr Naveed Shams has been appointed as the new vice president of clinical affairs at Santen Pharmaceutical Co., Ltd.

NCX 434, a new drug candidate form NicOx, is reported to improve oxygen saturation in the eye and preclinical data was recently presented at the Ocular Diseases & Drug Discovery Conference

Developed by US ophthalmologists, the surgical procedure DSAEK (Descemet's Stripping Automated Endothelial Keratoplasty) is increasingly being employed in German eye clinics too.

A team of scientists at UC Irvine (UCI) in California have taken the first step in developing transplant-ready retinas by creating an eight-layer, early-stage retina from human embryonic stem cells.

The European Uveitis Patient Association will present an award to Dr Richard Lee, NIHR clinical lecturer in ophthalmology at the University of Bristol at the forthcoming WOC for his recent research paper

Come and visit the Bausch + Lomb Booth No 16 at the WOC in Berlin to meet the Experts and ask questions. Explore Q2, delivering Quantity and Quality of Vision with the revolutionary Crystalens HD?, the premium accommodating IOL that gives high definition vision at all distances.

Does Google health have a place in practice management